THE ROLE OF VITAMIN-D3 IN THE PROLIFERATION OF A HUMAN-COLON CANCER CELL-LINE INVITRO
Authors:
- MJ WARGOVICHMWMJ WARGOVICH
- S SAEZSSS SAEZ
- B LEVINBLB LEVIN
- DM WILDRICKDWDM WILDRICK
- BM BOMANBBBM BOMAN
- 1 July 1987
- journal article
- research article
- Vol. 7 (4) , 817-821
Abstract
LoVo, a cultured colon cancer cell line, is shown to possess a receptor for 1,25-dihydroxy vitamin D3 (1.alpha.,25(OH)2D3) with a low capacity (28 fmol/mg protein) and high affinity (Kd: 1.9 .times. 10-210 M). When these cells were grown in monolayer culture in a chemically defined serum-free medium, a significant inhibition of proliferation was seen in the presence of 10 nM to 1 .mu.M of 1.alpha.,25(OH)2D3 (p < 0.005). Furthermore, 1.alpha.,25(OH)2D3 delayed early attachment of cells. After 8 days of treatment, aggregated cuboidal cells showed a marked change to an apparently spindle like morphology. The 1.alpha.,25(OH)2D3 growth-inhibitory effect was modulated by verapamil (1 .mu.M), a calcium channel blocker, hydrocortisone (1 .mu.M), and moxestrol (1mM), an estrogen analogue, and 2% charcoal-treated fetal bovine serum. This study represents the first demonstration of 1.alpha.,25(OH)2D3 modulation of growth of human colon cells.Keywords
This publication has 4 references indexed in Scilit:
- INHIBITION OF HUMAN CANCER CELL-GROWTH BY 1,25-DIHYDROXYVITAMIN-D3 METABOLITES1983
- GLUCOCORTICOID REGULATION OF 1,25(OH)2VITAMIN D3RECEPTORS: DIVERGENT EFFECTS ON MOUSE AND RAT INTESTINEEndocrinology, 1982
- An estrogen-stimulated 1,25-dihydroxyvitamin D3 receptor in rat uterusBiochemical and Biophysical Research Communications, 1981
- NORMAL AND MALIGNANT BREAST TISSUE IS A TARGET ORGAN FOR 1, 25‐(OH)2 VITAMIN D3Clinical Endocrinology, 1980